BIOMAT Database Logo BIOMAT Database Logo

Tracheal allotransplantation after withdrawal of immunosuppressive therapy. 2010

Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Department of Otolaryngology and Head and Neck , University Hospital Leuven, Leuven, Belgium. pierre.delaere@med.kuleuven.be

Reconstruction of long-segment tracheal defects requires a vascularized allograft. We report successful tracheal allotransplantation after indirect revascularization of the graft in a heterotopic position. Immunosuppressive therapy was administered before the operation, and the tracheal allograft was wrapped in the recipient's forearm fascia. Once revascularization was achieved, the mucosal lining was replaced progressively with buccal mucosa from the recipient. At 4 months, the tracheal chimera was fully lined with mucosa, which consisted of respiratory epithelium from the donor and buccal mucosa from the recipient. After withdrawal of immunosuppressive therapy, the tracheal allograft was moved to its correct anatomical position with an intact blood supply. No treatment-limiting adverse effects occurred.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D005260 Female Females
D005542 Forearm Part of the upper extremity in humans and primates extending from the ELBOW to the WRIST. Antebrachium,Antebrachiums,Forearms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014132 Trachea The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi. Tracheas
D014133 Tracheal Diseases Diseases involving the TRACHEA. Disease, Tracheal,Diseases, Tracheal,Tracheal Disease

Related Publications

Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
[Tracheal allotransplantation after withdrawal of immunosuppressive therapy].
October 2010, Bulletin de l'Academie nationale de medecine,
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation.
November 2007, Transplantation,
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Withdrawal of immunosuppressive therapy after developing melanoma.
May 2004, Journal of the American Academy of Dermatology,
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Withdrawal of steroids after cadaveric kidney allotransplantation on maintenance triple therapy.
February 1989, Transplantation proceedings,
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Tracheal allotransplantation after varying terms of cryopreservation.
November 1998, Transplantation proceedings,
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy.
August 1993, Journal of internal medicine,
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Renal allotransplantation in humans. I. Systemic immunosuppressive therapy.
February 1970, Archives of surgery (Chicago, Ill. : 1960),
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Short-course immunosuppression after tracheal allotransplantation in dogs.
May 1995, The Journal of thoracic and cardiovascular surgery,
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
[Immunosuppressive therapy in kidney allotransplantation. Theoretical and practical aspects].
January 1974, Eksperimental'naia khirurgiia i anesteziologiia,
Pierre Delaere, and Jan Vranckx, and Geert Verleden, and Paul De Leyn, and Dirk Van Raemdonck, and
Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
October 2008, Experimental hematology,
Copied contents to your clipboard!